Back to Journals » Drug Design, Development and Therapy » Volume 9

Brentuximab vedotin for treatment of relapsed or refractory malignant lymphoma: results of a systematic review and meta-analysis of prospective studies

Total article views   HTML views PDF downloads Totals
11,627 Dovepress* 9,953+ 1,952 11,905
PubMed Central* 1,674 687 2,361
Totals 11,627 2,639 14,266
*Since 20 April 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar